For Industry.
Cooperating in finding solutions for patients.
WHAT CAN EMHA DO FOR THE INDUSTRY.
Cooperating in finding solutions for patients.
Working together is the only way to find effective and lasting solutions for migraine sufferers.
By encouraging research, supporting projects and working to distribute reliable information, we can achieve a better quality of life for all patients living with migraine.

EMHA PROJECTS
Raising awareness to change the future under #TheMigraineMovement

The Invisible Hormonal Pattern
In 2025, EMHA launched the largest European survey on hormonal migraine. The questionnaire targeted the general population, with 5,410 women screened-positive for migraine, forming the sample of the survey. With oversight from an interdisciplinary Scientific Committee, we set out to understand how hormonal life stages-menstruation, pregnancy, menopause-affect migraine, and how healthcare responds.

The Migraine Scoring System
A new tool designed by Europe’s leading migraine specialists to help patients, physicians, and society to better understand and communicate about migraine.

1VoiceSummit – Lundbeck
Lundbeck’s #1VoiceSummit brings together the “glocal” advocacy community to exchange ideas, collaborate and partner up to find ways to amplify the voice of people with lived experience of brain disease.

Brain Health Mission – EAN
The Brain Health Mission is a collaborative initiative launched by the European Academy of Neurology to improve brain health globally. By bringing together governments, healthcare providers, researchers, advocates, and communities, we work to prevent brain disorders, support early diagnosis, and promote interventions that enhance mental and neurological well-being.

MOVEMI 2026
MOVEMI – Moving away from migraine is a European-funded project that promotes physical activity as a key tool for migraine prevention and mental health improvement, with a strong focus on inclusion and women’s health.
The project brings together municipalities, healthcare professionals, patient organisations, academic institutions, and communication experts from across Europe to develop innovative, inclusive, and evidence-based solutions for people living with migraine.

Hospital@Home 2026
Hospital@Home Hospital@Home (H@H) is a European initiative that brings hospital-level care directly to patients’ homes, transforming how chronic and complex conditions are diagnosed, monitored, and treated. Using intelligent digital technologies, AI-enabled decision support, and patient-centered care models, H@H sets the foundation for future integrated, sustainable healthcare systems across Europe. The project aims to: Hospital@Home (H@H)
COLLABORATIVE SUPPORTERS GUIDELINES
Working with the pharmaceutical and biotech industries.
Cooperate to improve the life quality of all the migraine sufferers community.
Abbvie
Organon
Lundbeck
Teva
Pfizer
Ipsen
Grünenthal
COLLABORATORS
We have the support of all of them.
VISIT AHMA
ANNUAL REPORT
EMHA Activities Report 2024
This EMHA Activities Report 2024 details our efforts over the past year, highlighting our achievements, the challenges we faced, and the initiatives we implemented.


